MLMiwoo Lee

Miwoo Lee

*This is an algorithmically generated author record based on publicly available information.

Miwoo Lee has a total of 42 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Development of a Machine Learning-Based Model for Classifying Depression Using Physiological and Psychological Indicators

    by Sooah Jang, Jinsoo Park, HyunKyung Shin, Miwoo Lee, Vin Ryu, Minji Bang, June-Ho Seo, Tae Hui Kim, Young-Chul Jung, Manjae Kwon, et al.

    Objective This study aimed to develop and evaluate machine learning-based models for classifying depression symptoms using salivary hormone markers (cortisol and dehydroepiandrosterone [DHEA]) and psychological indicators from depression screening devices, and to determine the extent to which salivary hormone markers contribute to depression symptom classification.Methods Two models were developed, a multi-class classification (four degrees of depression) and a binary classification model (normal vs. depression), using psychological indicators that assess depression symptoms, protective and vulnerability factors, and physiological indicators including salivary cortisol and DHEA. Each model was evaluated both with and without physiological indicators. Data from 368 individuals were used for model training, with 92 individuals reserved for independent testing. Out of 36 variables, including psychological indicators from the PROtective and Vulnerable factors battEry test and physiological markers (e.g., salivary cortisol and DHEA), 24 non-demographic variables with independent contributions were selected, excluding demographic information. To ensure model robustness, overfitting risks were mitigated using k-fold cross-validation, class weight balancing, and grid search optimization. Model performance was evaluated based on accuracy, precision, recall, and receiver operating characteristic values.Results The multi-class classification model achieved 85.9% and 76.1% accuracy with and without physiological indicators, respectively. The binary classification model (depression presence or absence) achieved 97.8% accuracy both with and without physiological indicators.Conclusion The machine learning models demonstrated high accuracy in depression classification, showing a noteworthy improvement in classification performance when integrating psychological and physiological markers. Future clinical trials will be conducted to secure additional clinical data to verify the model’s reliability and clinical validity.

  • Open Access

    Efficacy and Usability of a Virtual Reality-Based Cognitive Behavioral Therapy Program (CHEEU. Forest N) for Patients with Major Depressive Disorder: A Randomized, Non-inferiority Confirmatory Trial (Preprint)

    by Miwoo Lee, Sooah Jang, Heeyeon Kim, Jin Sun Ryu, June-Ho Seo, Tae Hui Kim, Yeon Jae Woo, Sin Young Ko, Jiwun Song, Byung-Hoon Kim, et al.

    BACKGROUND Major depressive disorder (MDD) poses a substantial global health burden, with a high suicide risk and limited treatment accessibility. Although cognitive behavioral therapy (CBT) shows robust efficacy, practical barriers, including therapist availability and time constraints, limit its implementation. Virtual reality (VR)-based interventions offer an immersive and accessible alternative. However, rigorous evidence for VR-based CBT for depression remains limited. OBJECTIVE To evaluate the efficacy and usability of CHEEU. Forest N, a VR-based CBT program integrating components of mindfulness-based cognitive, mentalization-based, and dialectical behavior therapies, compared with standard pharmacotherapy in patients with MDD. METHODS This multicenter, randomized, parallel-group, assessor-blinded, non-inferiority confirmatory trial enrolled 134 adults aged between 19 and 55 years who met the DSM-5 criteria for MDD with Patient Health Questionnaire-9 scores ≥7 and moderate suicidality. The participants were randomized 1:1 to receive 6 weekly VR-based CBT sessions (VR group, n=67) or standard antidepressant treatment with brief clinical interviews (treatment-as-usual; TAU group, n=67). The primary outcome was the change in the Korean version of the Quick Inventory of Depressive Symptomatology-Clinician-Rated (K-QIDS-C) scores from baseline to post-treatment (week 6), with a non-inferiority comparison. The secondary outcomes included self-reported depression, anxiety, stress, suicidality, quality of life, presence, and usability. The per-protocol analysis included 116 participants (58 in each group). RESULTS Both groups demonstrated a significant reduction in the severity of their depressive symptoms. The adjusted between-group difference in K-QIDS-C scores was 0.13 points (SE=0.91, 95% CI: –1.66 to 1.93, p=.883), confirming non-inferiority of VR to TAU (upper CI bound 1.93<5.0). Response rates were comparable between the VR (44.8%) and TAU (43.1%) groups (χ²=0.04, p=.852), as were the remission rates (25.9% vs. 27.6%, χ²=0.04, p=.834). For suicidality, 50% of the VR participants achieved remission compared with 43% in TAU (χ²=0.55, p=.457). No significant between-group differences emerged for the secondary outcomes, including anxiety, stress, or quality of life. Usability ratings were high (mean composite score 3.73±0.62/5.0), with participants reporting increased depression literacy (7.43±1.94/10) and willingness to recommend the program (7.47±2.01/10). Simulator sickness decreased significantly with repeated exposure. Baseline presence was correlated with usability (r=0.46, p<.001) but not with clinical outcomes. No serious adverse events occurred. CONCLUSIONS The VR-based CBT intervention demonstrated therapeutic efficacy equivalent to that of standard pharmacotherapy in treating depression, particularly in reducing suicidal ideation and increasing user satisfaction. These findings support VR-based digital therapeutics as safe, effective, and accessible alternatives or adjunctive treatment options for depression, warranting further investigation of long-term outcomes. CLINICALTRIAL This trial was registered with the Clinical Research Information Service (KCT0009868).

  • Open Access

    A Preliminary Study on the Validation of a Contactless Mental Health Assessment Service for Disaster Related Distress: Focusing on the Relationship Between Insomnia and Stress Sensitivity

    by Miwoo Lee, HyunKyung Shin, Eun Young Kim, Sin Young Ko, Min Kyung Shin, Uranbileg Khishigbayar, Sooah Jang, Jeong-Ho Seok

    이미우, et al. J Korean Neuropsychiatr Assoc. 2025 Nov;64(4):266-276. https://doi.org/10.4306/jknpa.2025.64.4.266

  • Open Access

    Development of the Battery Test for Screening of Depression and Mental Health: PROtective and Vulnerable factors battEry test–Light version

    by Ju-Yeal Lee, Hyunkyung Shin, Sun-Woo Choi, Miwoo Lee, Saeeun Jeong, Shin-Goo Park, Joohan Kim, Jeong-Ho Seok, Sooah Jang

    이주열, et al. J Korean Neuropsychiatr Assoc. 2025 May;64(2):58-76. https://doi.org/10.4306/jknpa.2025.64.2.58


  • Open Access

    Virtual Reality-Based Cognitive Behavior Therapy for Major Depressive Disorder: An Alternative to Pharmacotherapy for Reducing Suicidality

    by Miwoo Lee, Sooah Jang, Hyun Kyung Shin, Sun-Woo Choi, Hyung Taek Kim, Jihee Oh, Ji Hye Kwon, Youngjun Choi, Suzi Kang, In-Seong Back, et al.

    Lee M, et al. Yonsei Med J. 2025 Jan;66(1):25-36. https://doi.org/10.3349/ymj.2024.0002


  • Open Access

    Successful Treatment of Multicentric Reticulohistiocytosis with a Combination of Infliximab, Prednisolone and Methotrexate

    by Mi-Woo Lee, Eun-Young Lee, Young Il Jeong, Jee-Ho Choi, Kee-Chan Moon, Jai-Kyoung Koh